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Abstract
Kaposi’s sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi’s sarcoma (KS) as
well as two lymphoproliferative diseases, primary effusion lymphoma and multicentric Cas-
tleman’s disease. KSHV encodes viral proteins, such as K1, that alter signaling pathways
involved in cell survival. Expression of K1 has been reported to transform rodent fibroblasts,
and K1 transgenic mice develop multiple tumors, suggesting that K1 has an important role
in KSHV pathogenesis. We found that cells infected with a KSHV virus containing a WT K1
gene had a survival advantage under conditions of nutrient deprivation compared to cells
infected with KSHV K1 mutant viruses. 5’ adenosine monophosphate-activated protein
kinase (AMPK) responds to nutrient deprivation by maintaining energy homeostasis, and
AMPK signaling has been shown to promote cell survival in various types of cancers.
Under conditions of AMPK inhibition, we also observed that cells infected with KSHV con-
taining a WT K1 gene had a survival advantage compared to KSHV K1 mutant virus
infected cells. To explore the underpinnings of this phenotype, we identified K1-associated
cellular proteins by tandem affinity purification and mass spectrometry. We found that the
KSHV K1 protein associates with the gamma subunit of AMPK (AMPKγ1). We corrobo-
rated this finding by independently confirming that K1 co-immunoprecipitates with
AMPKγ1. Co-immunoprecipitations of wild-type K1 (K1WT) or K1 domain mutants and
AMPKγ1, revealed that the K1 N-terminus is important for the association between K1 and
AMPKγ1. We propose that the KSHV K1 protein promotes cell survival via its association
with AMPKγ1 following exposure to stress.
Author Summary
Infectious agents such as Kaposi’s sarcoma associated herpesvirus (KSHV) are etiologic
agents of human cancer. KSHV-infected cells must survive various environmental stresses.
Cells infected with KSHV express viral proteins that alter normal cellular processes to pro-
mote cell survival and viral persistence.We found that the KSHV K1 protein promotes
survival under conditions of cellular stress, and that this survival advantage is at least
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partially dependent on the association of K1 and the cellular protein AMP-activated pro-
tein kinase (AMPK).We also observed increasedAMPK activity in K1-expressing cells
compared to EV following exposure to metabolic stress. Several reports suggest that
AMPK signalingmay contribute to tumor development by promoting cell survival. Our
results suggest that KSHV K1 modulates cellular AMPK function to enhance the survival
of KSHV-infected cells in order to promote viral persistence.
Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of the endothelial can-
cer, Kaposi’s sarcoma (KS), and two B-cell lymphomas including primary effusion lymphoma
(PEL) and multicentric Castleman’s disease (MCD) [1–3]. KSHV-related malignancies primar-
ily arise in immune-suppressed individuals including HIV-positive individuals and organ
transplant recipients, although these cancers can also occur in the absence of immunosuppres-
sion. KS is a common cancer in some sub-Saharan African countries [4, 5].
KSHV is a double-strand DNA gammaherpesvirus that is 165 to 170 kb long [6]. The
KSHV genome contains multiple open reading frames that are conserved among other herpes-
viruses, and genes K1-K15 that are unique to KSHV [7]. Similar to other herpesviruses,KSHV
has latent and lytic phases. Upon entering the host cell, KSHV typically establishes latency and
expresses a limited number of viral proteins. Upon reactivation, which can be induced in vitro
with various compounds such as 12-O-tetradecanoylphorbol-13-acetate (TPA), histone deace-
tylase (HDAC) inhibitors, and TLR 7/8 ligands, KSHV enters the viral lytic cycle resulting in
the production of infectious virions [7, 8].
Both latent and lytic phases appear to be important for KSHV pathology. Expression of
latent genes generally promotes the survival of the infected cell and persistence of infection
during cell division. Lytic gene expression results in the production of inflammatory cytokines,
pro-angiogenic factors and viral proteins that subvert the host immune system and promote
virion production. KSHV K1 is primarily expressed during the lytic phase although recent
studies indicate that K1 is also expressed at low levels during latency [9–11].
K1 is a 46-kDa transmembrane glycoprotein that contains a C-terminal immunoreceptor
tyrosine-based activation motif (ITAM) analogous to the signalingmolecules in the B-cell
receptor (BCR) signaling complex [12]. The K1 ITAM has been found to interact with various
SH2 containing signalingmolecules, including among others, the p85 regulatory unit of phos-
phoinositide-3-kinase (PI3K) [13]. K1 has been shown to initiate a signaling cascade leading to
intracellular calciummobilization, upregulation of NFAT and AP-1 transcription factors, and
production of inflammatory cytokines [12, 13]. It is thought that K1 is maintained in an acti-
vated state by oligomerization of the K1 ectodomain and subsequent phosphorylation of the
ITAM tyrosines by Src family kinases [14].
K1 has a role in KSHV-induced tumor development. K1 expression immortalizes primary
endothelial cells, transforms rodent fibroblasts, and K1 transgenic mice develop spindle cell
sarcomatoid tumors and plasmablastic lymphoma, suggesting that the K1 protein is important
for KSHV-induced tumor development [15–17]. These cancerous phenotypes may be due to
K1’s modulation of cellular proteins in signaling pathways that are important for cell survival.
We and others have previously shown that K1 activates the PI3K/Akt/mTOR pathway and
protects against Fas-mediated apoptosis [18–20].
In our current studies, we observed that cells infected with KSHV viruses containing a
wild-typeK1 gene (KSHV-K1WT and KSHV-K1REV) displayed a survival advantage under
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conditions of nutrient deprivation compared to viruses containing mutant K1 genes
(KSHV-K15XSTOP and KSHVΔK1). To understand the underpinnings of this phenotype, we
performed tandem affinity purification and mass spectrometry to identify K1 binding proteins.
We found that KSHV K1 associates with the gamma subunit of 5’adenosinemonophosphate-
activated protein kinase (AMPKγ1).
AMPK is a heterotrimeric serine/threoninekinase composed of an alpha catalytic subunit
and two regulatory subunits, beta and gamma [21]. Each subunit is part of a larger isoform
family including the following subunit isoforms: α1, α2, β1, β2, γ1, γ2 and γ3 [22–25]. The iso-
forms of each subunit are found in different compartments within the cell. AMPKα1 and
AMPKα2 localize to the cytoplasm. AMPKα2 also localizes to the nucleus in rat pancreatic and
HeLa cells [26]. AMPKα1 and AMPKβ1 are in the perinuclear region in HEK-293 cells [27].
Mammalian AMPKα2, AMPKβ1, and AMPKγ1 are in the nuclei of neurons [28]. The subunit
isoforms can come together in various combinations to make different heterotrimers. The dif-
ferences in function of each heterotrimer are still under investigation. The presence of the three
subunits is necessary for full activation of AMPK and the regulatory subunits stabilize expres-
sion of the catalytic α subunit [29].
AMPK responds to stresses that reduce ATP levels by inhibiting anabolic and activating cat-
abolic pathways to maintain energy homeostasis [30]. Binding of adenosinemonophosphate
(AMP) to the gamma subunit allosterically activates AMPK and promotes phosphorylation of
AMPKα at Thr172 by upstream kinases [31–33]. AMPK also responds to environmental stress
factors that reduce cellular ATP levels such as hypoxia [34–37].
The role of AMPK as a tumor promoter is actively being explored [38, 39]. Some studies
suggest that AMPK promotes tumor cell survival in vitro and in vivo. Inhibition of AMPK
results in reduced prostate cell survival and increased apoptosis under normal and stressed
conditions [40, 41]. AMPK has also been shown to promote survival in multiple myeloma,
colorectal and glioma cancer cell lines [42–44]. In vivo, AMPK signaling was found to be ele-
vated in developing tumors in a glioblastoma rat model [45]. Moreover, there is reduced in
vivo tumor growth of xenografts prepared from transformed AMPKα1/α2-null MEFs com-
pared to wild-type (WT)MEFs [37]. Thus, there is accumulating evidence suggesting that
AMPKmay promote cancer cell survival and tumor development.
Here we report that K1 binds AMPKγ1 and that this interaction is important for K1’s ability
to enhance cell survival.
Results
Cells infected with KSHV containing WT K1 display increased survival
BAC16 recombinant viruses containingWTK1 (KSHV-K1WT and KSHV-K1REV) were made
as previously described [46]. Immortalized human umbilical vein endothelial cells (HUVEC)
[17] or iSLK cells were infected with BAC16 recombinant viruses containingWT K1 (KSHV-
K1WT and KSHV-K1REV) or mutant K1 (KSHV-K15XSTOP and KSHVΔK1) genes [46]. These
recombinant BAC16 viruses contain a GFPmarker to monitor cell infectivity [46]. Both
HUVEC and iSLK cells were stably selected until 100% of cells were green indicating that all
cells were infected with these viruses.
Each HUVEC cell line was then subjected to stress by withdrawing serum and growth fac-
tors. KSHV-K1WT and KSHV-K1REV (revertant) harbor a wild type K1 gene while the
KSHV-K15XSTOP and KSHVΔK1 lack K1 (Fig 1A). We evaluated cell viability at various time-
points by MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium, inner salt), which is a measure of metabolic activity, and trypan blue
exclusion assay. At 24, 48, and 72 hours following nutrient deprivation, HUVEC infected with
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Fig 1. KSHV K1 mutant infected cells exhibit decreased survival following nutrient deprivation.
(A) KSHV-K1WT and KSHV-K1REV (revertant) harbor a wild type K1 gene. The KSHV-K15XSTOP has a K1
mutant gene that contains 5 stop codons. Three of the stop codons follow the first start codon of the K1 gene.
The other two stop codons replace two downstream ATG codons at positions 481 and 763 in the K1 gene. The
KSHVΔK1 mutant has had the K1 gene replaced by a RpsL-Neo cassette. Hence, the KSHV-K15XSTOP and
KSHVΔK1 are not able to express any portion of the K1 protein. The grey box represents FLAG and horizontal
lines represent the stop codons in KSHV-K15XSTOP. HUVEC infected with KSHV-K1WT, KSHV-K15XSTOP,
KSHVΔK1 or KSHV-K1REV were starved of serum and growth factors for 24, 48 and 72 hours. (B) The
proportion of metabolically active cells within each group was determined using an MTS assay. Error bars are
the standard deviation of biological triplicates. GraphPad Prism was used to determine one-way ANOVA and
Tukey’s post-test. *P<0.05, **P<0.005 (C) The percent of viable cells/well for each group was determined by
trypan blue exclusion assay. Percent was calculated by normalization to total number of cells plated. Error bars
are the standard deviation of biological triplicates. (D) KSHV-K1WT, KSHV-K15XSTOP, KSHVΔK1, and
KSHV-K1REV infected iSLK cells were cultured without serum. Cell viability was determined by trypan blue
exclusion. Error bars are the standard deviation of biological triplicates.
doi:10.1371/journal.ppat.1005985.g001
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KSHV-K1WT and KSHV-K1REV had more viable cells compared to the KSHV-K15XSTOP and
KSHVΔK1HUVEC as observedusing the MTS assay (Fig 1B). The differences were greatest at
72 hours post-nutrient deprivation.
To further substantiate these results, we also performed trypan blue exclusion assays and
observed that the KSHV-K1WT and KSHV-K1REV infected cells were more viable compared to
the cells infected with KSHV-K15XSTOP and KSHVΔK1 infected cells at 48 and 72 hours (Fig
1C). Similar to the MTS assay results, we observed reductions in cell viability in KSHV-
K15XSTOP and KSHVΔK1 infected cells compared to KSHV-K1WT and KSHV-K1REV infected
cells at 24, 48, and 72 hours post-starvation (Fig 1C). When we added serum and growth fac-
tors back to the media of KSHV-K1 WT and K1 mutant infected cells that had been starved for
72 hours, we noticed that there was still a reduction in viable KSHV-K1 mutant infected cells
compared to the number of viable KSHV-K1 WT infected cells by trypan blue exclusion assay
(S1B Fig). There is an increase in viable KSHV-K1 mutant cells from 72 hours of starvation to
72 hours of nutrient replenishment, just not to the same levels observed in KSHV-K1 WT
(S1A and S1B Fig).
Furthermore, iSLK cell lines stably infected with these same viruses (KSHV-K1WT,
KSHV-K1REV, KSHV-K15XSTOP and KSHVΔK1) were also evaluated following serumwith-
drawal. Every two days for a total of 12 days, we evaluated cell viability by trypan blue exclu-
sion. At all time-points following serumwithdrawal, we observed that KSHV-KTWT and
KSHV-K1REV infected iSLK cells had increased viability compared to KSHV-K15XSTOP and
KSHVΔK1 iSLK cells (Fig 1D). These findings suggest that K1 promotes KSHV-infected cell
survival in the context of the whole genome and under conditions of nutrient deprivation.
A major regulator of metabolic stress is AMP-activated protein kinase (AMPK). AMPK
responds to metabolic stress by activating catabolic pathways and inhibiting anabolic cell sig-
naling pathways to maintain energy homeostasis [47]. Because we observed that cells infected
with KSHV expressing a WT K1 gene had a survival advantage compared to cells infected with
KSHV K1 mutant viruses following exposure to metabolic stress, and AMPK is involved in
maintaining metabolic homeostasis, we hypothesized that K1 might modulate AMPK function.
To explore this possibility, we compared cell survival in HUVEC infected with KSHV-K1WT
and KSHV-K1REV wild-type viruses to KSHV-K15XSTOP and KSHVΔK1mutant viruses follow-
ing treatment with the AMPK inhibitor, compound C. Compound C is a reversible and com-
petitive inhibitor of ATP [48]. In the presence of 5μM ATP and absence of AMP, compound C
has a Ki of 109 ± 16 nM [48]. Compound C significantly prevents AMPK activation in vitro at
20 μM, and at 40 μM in cells treated with the AMPK activators metformin or AICAR [48].
According to Zhou et al., compound C has minimal impact on structurally related kinases such
as ZAPK, SYK, PKCθ, PKA and JAK3 [48]. Inhibition of AMPK by compound C has been
shown to induce cell death in various cell lines [41, 49].
We observed increased cell viability in KSHV-K1WT and KSHV-K1REV infected cells com-
pared to KSHV-K15XSTOP infected cells by MTS assay (Fig 2A). Corroborating these results, we
also observed increased cell viability in KSHV-K1WT and KSHV-K1REV compared to KSHVΔK1
infected cells, suggesting that cells infectedwithWTK1 virus are less sensitive to the stress
induced by AMPK inhibition than cells infectedwith the KSHV K1mutants (Fig 2B). As
expected, cell viability betweenKSHV-K1WT and KSHV-K1REV infected cells was essentially the
same (Fig 2A and 2B).
To determine whether KSHV-K1WT survival could be impacted by knock down of AMPK,
we treated HUVEC stably infected with KSHV-K1WT with AMPKα1 and AMPKα2 siRNA.
We observed reduced cell viability in HUVEC infected with KSHV-K1WT that had been treated
with AMPKα1 and AMPKα2 siRNA compared to cells treated with NS siRNA at 48 and 72
hours (S2A Fig). We also evaluated AMPKα1 and AMPKα2 expression by immunoblot to
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confirm knock down of AMPKα1and AMPKα2 (S2B Fig). This data suggests that when
AMPK is depleted, KSHV-K1WT cells are susceptible to cell death.
To evaluate the impact of K1 expression by itself on cell survival following treatment with
the AMPK inhibitor, compound C, we created FLAG epitope-taggedK1 (K1) or empty vector
(EV) HEK-293 stable cell lines. The EV or K1 HEK-293 cells were treated with increasing con-
centrations of compound C, and cell viability was evaluated by trypan blue exclusion assay. We
observed an increased number of viable cells in the K1 expressing cells compared to EV
expressing cells using two different concentrations (10 μM and 20 μM) of compound C (Fig
3A). We observed this difference at both 8 and 24 hours following incubation of the cells with
10 μM compound C (Fig 3B). In order to determine whether K1 protected from apoptosis
induced by AMPK inhibition, we also performed an assay to detect active caspase-3, which is
an indicator of apoptosis. Active caspase-3 levels were remarkably elevated in EV cells com-
pared to K1 expressing cells, suggesting that K1 protects cells from apoptosis when AMPK is
inhibited (Fig 3C). K1 expression in these cells was confirmed by a Western blot (Fig 3D). This
data suggests that K1 expression can keep cells alive by diminishing the effects of AMPK
inhibition.
The KSHV K1 protein associates with the gamma subunit of AMPK
(AMPKγ1)
To investigate how K1 may be promoting cell survival following exposure to metabolic stress,
we wanted to determine cellular proteins associated with K1. We identifiedK1-associated
Fig 2. Cells infected with KSHV containing WT K1 are more resistant to AMPK inhibition than cells
infected with KSHV K1 mutants. HUVEC infected with viruses containing a WT or mutant K1 gene were
treated with 20 μM of compound C for 48 hours. Metabolically active cells were determined by an MTS assay.
(A) The percent of metabolically active cells in HUVEC stably infected with the recombinant viruses
KSHV-K1WT, KSHV-K15XSTOP, and KSHV-K1REV. (B) The percent of metabolically active cells of HUVEC
stably infected with KSHV- K1WT, KSHVΔK1, and KSHV-K1REV. The percent was determined by normalizing to
DMSO (0.2%) control. Error bars represent the standard deviation of biological triplicates. GraphPad Prism
was used to determine one-way ANOVA and Tukey’s post-test. *P<0.02, **P<0.01, ***P<0.001.
doi:10.1371/journal.ppat.1005985.g002
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cellular proteins by performing tandem affinity purification of K1 fromHEK-293 cells and
subjecting cellular proteins bound to K1 to mass spectrometry.
Stable cell lines expressing a FLAG and HA double epitope-tagged version of K1 and EV
HEK-293 cells were generated as previously described [50]. For tandem affinity purification,
FLAG-HA-K1 or EV HEK-293 expressing cells were lysed with NP40 buffer. The clarified
lysates were incubated with anti-FLAGM2 affinity gel, washed with NP40 buffer, and then
eluted with 3X FLAG peptide. The eluates were subsequently incubated with an anti-HA resin,
washed with NP40 buffer and eluted. The eluates were resolved by sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and Coomassie stained. Only bands that were present in the K1
lane and absent in the EV lane were isolated and submitted for MALDI/TOF/TOFmass
Fig 3. K1 expression provides a survival advantage in cells treated with compound C. (A) HEK-293 cells stably expressing
empty vector (EV) or FLAG-K1 (K1) were treated in duplicate with 0 μM/ DMSO (0.2%), 20 μM compound C (CC) or 10 μM compound
C for 6–8 hours. (B) HEK-293 cells stably expressing EV or K1 were treated in duplicate with 0 μM/DMSO (0.1%) or 10 μM compound
C (CC) for 8 and 24 hours. Cell viability was determined by trypan blue exclusion assay. Percentages were derived from normalization
to vehicle treated samples. (C) The level of caspase-3 activity was determined in duplicate samples and normalized to cell number of
each sample. (D) EV or K1 HEK-293 cells treated with either 0 μM/DMSO (0.1%) or 10 μM compound C for 6 hours and immunoblotted
for K1 and tubulin. Statistical significance was evaluated by Student’s t test. *P<0.05, **P<0.005.
doi:10.1371/journal.ppat.1005985.g003
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spectrometry (S3A Fig). AWestern blot of the affinity-purifiedeluate was also performed to
confirm successful pull-down of FLAG-HA-K1 (S3B Fig). Using mass spectrometry, we found
AMPKγ1 associated with K1 (Fig 4A). We also observed an association betweenK1 and heat-
shock protein 90 (HSP90) (Fig 4A), which confirmed our previous report on the association of
K1 with HSP90 [50].
Next, we constructed a V5 epitope-taggedAMPKγ1 (AMPKγ1) in pcDNA3 vector. To con-
firm the association betweenK1 and AMPKγ1 as determined by mass spectrometry, we tran-
siently expressed AMPKγ1 in HEK-293 cells stably expressing EV or FLAG epitope-taggedK1
(K1). We performed a co-immunoprecipitation by incubating EV- or K1-expressing HEK 293
clarified lysates containing equal amounts of protein with anti-V5 antibody to pull down the
V5 epitope-taggedAMPKγ1.We detected the multimer and monomer forms of K1 co-immu-
noprecipitating with AMPKγ1 in K1-expressing cells, but not from EV control cells (Fig 4B).
To further substantiate the association betweenK1 and AMPKγ1, we performed the reverse
immunoprecipitation and immunoprecipitated K1.We observed that AMPKγ1 co-immuno-
precipitated with K1 from K1-expressing cells but not from EV control cells (Fig 4C).
In the cell, AMPKγ1 complexes with AMPKα1 and AMPKβ1. In addition to AMPKγ1, we
next wanted to determine whether the other AMPK subunits were part of the protein complex
associated with K1. We transfected V5-AMPKγ1 in HEK-293 cells stably expressing empty
vector (EV) or FLAG-K1 (K1), immunoprecipitated V5-AMPKγ1, and probed for endogenous
AMPKα1 and AMPKβ1. In addition to detectingK1 as we previously observed,we also
observed the expression of AMPKα1 and AMPKβ1 (Fig 5A), suggesting that there is an associ-
ation betweenK1 and the three subunits of AMPK. Next, we determinedwhether we could
detect association of K1 and endogenous AMPK. As the commercially available AMPKγ1
antibody is not appropriate for immunoprecipitation, we immunoprecipitated endogenous
Fig 4. K1 associates with AMPKγ1. (A) Number of PRKAG1 (AMPKγ1) and HSP90 peptides identified in
association with K1 by mass spectrometry. (B) HEK-293 cells stably expressing empty vector (EV) or
FLAG-K1 (K1) were transfected with V5-AMPKγ1 (AMPKγ1). AMPKγ1 was immunoprecipitated, and
immunoblotted for K1 or AMPKγ1. (C) HEK-293 cells stably expressing EV or K1 were transfected with
AMPKγ1 or EV (pcDNA3). K1 was immunoprecipitated and immunoblotted for AMPKγ1 or K1.
doi:10.1371/journal.ppat.1005985.g004
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AMPKβ1 and probed for K1 (Fig 5B). Upon AMPKβ1 immunoprecipitation, we detectedK1,
which further confirmed an association betweenK1 and the endogenous AMPK complex
(Fig 5B).
K1 has an immunoglobulin-like N-terminus, a transmembrane region, and a cytoplasmic
tail containing an ITAM. To identify the region of K1 that associates with AMPKγ1, we per-
formed co-immunoprecipitations of various FLAG-taggedK1 domain deletionmutants and
V5-taggedAMPKγ1.We transiently expressed V5-AMPKγ1 (AMPKγ1) along with one of the
following in HEK-293 cells: K1WT, K1 lacking the C-terminus (K1ΔCT), or lacking the N-termi-
nus (K1ΔNT). We also transfected an equivalent amount of EV (pcDNA3) and K1WT as a con-
trol. The construction of the FLAG-tagged K1 mutants has previously been described [50]. We
immunoprecipitated K1WT, K1ΔCT, or K1ΔNT and probed for V5-tagged AMPKγ1 (Fig 5C). As
previously observed,we detected co-immunoprecipitation of AMPKγ1 and K1WT (Fig 5C, lane
1). We also detected co-immunoprecipitation of AMPKγ1 and K1ΔCT indicating that the K1 C-
terminus is not important for K1 and AMPKγ1 association (Fig 5C, lane 2). We did not observe
co-immunoprecipitation of AMPKγ1 and K1ΔNT suggesting that AMPKγ1 associates with K1
via the K1 N-terminus (Fig 5C, lane 3).
K1 and AMPK subunits are localized to cellular membranes
About 10–20% of K1 is localized to the plasma membrane with the major fraction of K1 being
found in the endoplasmic reticulum [51]. K1 can also be internalized and internalization is
associated with K1 signaling [52]. Additionally, all three subunits of AMPK have been shown
to localize to the cellular membrane fraction [27]. We wanted to evaluate the localization of the
endogenous AMPK subunits in EV- and K1-expressing stable HEK-293 cells. We lysed equal
numbers of EV- and K1-expressing HEK-293 cells and separated the cellular fractions. The
Fig 5. The K1 N-terminus is important for association with AMPKγ1. (A) HEK-293 cells stably expressing empty
vector (EV) or FLAG-K1 (K1) were transfected with V5-AMPKγ1 (AMPKγ1). AMPKγ1 was immunoprecipitated, and blots
were probed for AMPKγ1, endogenous AMPKα1, endogenous AMPKβ1 and K1. (B) Endogenous AMPKβ1 was
immunoprecipitated from EV or K1 expressing HEK-293 cells. The blots were probed for K1 or AMPKβ1. (C) HEK-293
cells were transiently transfected with AMPKγ1 and with one of the following: K1WT, K1ΔCT or K1ΔNT. An equivalent
amount of EV (pcDNA3) was also transfected along with K1WT. We immunoprecipitated the various K1 domain mutants,
and immunoblotted for AMPKγ1 or K1.
doi:10.1371/journal.ppat.1005985.g005
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fractions were then resolved by SDS-PAGE andWestern blot. The blots were probed using
antibodies specific for each AMPK subunit and isoform. In addition to being localized to the
cytoplasm, we observed that AMPKα, AMPKβ1, and AMPKγ1 were detected in the cellular
membrane fraction (Fig 6A). Along with the AMPK subunits, K1 was also found in the mem-
brane fraction (Fig 6A). We evaluated the purity of the cytoplasmic,membrane, and nuclear
Fig 6. K1 and AMPK associate in membranes in the perinuclear area of the cell. (A) HEK-293 cells stably
expressing empty vector (EV) or FLAG-K1 (K1) were lysed and fractionated into cytoplasmic, membrane and nuclear
fractions. Immunoblots were probed for endogenous AMPK subunit and isoforms. (B) HUVEC stably expressing empty
(EV) or FLAG-K1 (K1) were fixed and permeabilized. Cells were then stained with anti-FLAG directly conjugated to FITC
antibody, and an AMPKβ1/2 antibody, followed by an anti-rabbit conjugated to Alexa Fluor 647. Nuclei were stained with
DAPI. Stained HUVEC were evaluated with a Zeiss 700 confocal microscope using a 63X oil objective. Mander’s overlap
coefficient (R = 0.83) was generated using ImageJ. (C) HEK-293 cells were transiently transfected with EV (pcDNA3),
K1WT, K1ΔCT and K1ΔNT. Cell lysates were separated into membrane, cytoplasmic and nuclear fractions. We evaluated
the membrane fraction for expression of the K1 domain deleted mutants by immunoblot. We also immunoblotted for AIF
(membrane), MEK1/2 (cytoplasm) and Histone H3 (nucleus). (D) HEK-293 cells were transiently transfected with the
constructs described in (C) with the addition of AMPKγ1. Cell lysates were separated into membrane, cytoplasmic and
nuclear fractions. We immunoprecipitated FLAG K1 and immunoblotted for AMPKγ1 or FLAG using only the membrane
fraction.
doi:10.1371/journal.ppat.1005985.g006
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fractions by probing for MEK1/2, K1, and histone H3 respectively (Fig 6A). These proteins are
restricted to each of these fractions. Based on these findings, we conclude that K1 and multiple
AMPK subunits and isoforms (without over expression) are localized to the cellular membrane
fraction, suggesting that K1 associates with AMPK in the cellular membrane.
We subsequently evaluated localization of FLAG-K1 (K1) and endogenous AMPK by immu-
nofluorescence staining. Because there is no available AMPKγ1 antibody that was appropriate
for immunofluorescence staining, and we had determined that AMPKβ1 co-localizedwith K1
(Fig 5B), we stained for K1 and endogenous AMPKβ1/2 in EV- or K1- stably expressing
HUVEC.We fixed the cells with formaldehyde, washed and then permeabilized the cells with
Triton-X-100. We stained cells with FLAG-FITC to detect FLAG-K1 and AMPKβ1/2 antibodies
followed by an anti-rabbit Alexa Fluor 647 secondary antibody. By confocal microscopy, we
acquired z-stacks on fully stained EV and FLAG-taggedK1 HUVEC (Fig 6B). We also com-
pleted z-stacks on controls containing only the secondary anti-rabbit AF647 in order to demon-
strate that the staining for AMPKβ1/2 is specific and not due to non-specific secondary staining.
We observed co-localization of K1 and endogenous AMPKβ1/2 in the perinuclear area (Fig 6B)
as determined by a Mander’s overlap coefficient of 0.83, which was determined using ImageJ
software. The EV transfected cells stained positive for AMPKβ1/2 but not K1, as expected.
As described above, we observed (Fig 5C) that K1ΔNT does not associate with AMPKγ1 by
co-immunoprecipitation. This lack of associationmay be due to the fact that the two proteins
do not interact or because K1ΔNT is mislocalized in the cell. In order to confirm that K1ΔNT is
expressed in the membrane but still does not interact with AMPK, we transiently expressed
K1ΔNT, and fractionated the cell lysates into cytoplasmic, membrane, and nuclear components.
We then evaluated K1ΔNT expression in the membrane fraction by immunoblotting for K1ΔNT.
We observed that K1ΔNT is expressed in the membrane fraction (Fig 6C). Next, we transiently
transfected the K1 domain deletionmutants and AMPKγ1.We separated the lysates into mem-
brane, cytoplasmic, and nuclear fractions.We removed detergent from the membrane fraction
by spin column removal and completed a bicinchoninic acid assay (BCA assay) to determine
the protein concentrations for each sample. Using equal amounts of protein, we immunopre-
cipitated EV (pcDNA3), K1WT, K1ΔCT, or K1ΔNT and probed for V5-taggedAMPKγ1 in the
membrane fraction.We detected K1WT and AMPKγ1 association, but we did not detect K1ΔNT
and AMPKγ1 association in the membrane fraction (Fig 6D) corroborating our previous
findings.
K1 and AMPK association is important for cell survival following
exposure to stress
Thus far, we have observed that KSHV K1 promotes survival in stressed cells, and K1 associates
with AMPK via the K1 N-terminus.We next wanted to determine whether the association of
K1 and AMPK is important for the survival advantage observed in stressed cells. We generated
lentivirally transducedHEK-293 cells stably expressing FLAG epitope-taggedK1WT, K1ΔCT,
K1ΔNT and empty vector (EV). We treated these cells with the AMPK inhibitor, compound C,
and evaluated cell viability using the MTS assay. We observed an increased percentage of viable
K1WT expressing cells when AMPK was inhibited, compared to cells expressing K1ΔNT. This
result suggests that the association betweenK1 and AMPK is important for survival in stressed
cells (Fig 7A). Surprisingly, we also observed that K1ΔCT expressing cells appear sensitive to
AMPK inhibition, indicating that the K1-C terminus is also important for survival in stressed
cells (Fig 7A). We confirmed expression of the various K1 constructs by completing a Western
blot using an anti-FLAG antibody or an anti-K1 antibody (Fig 7B). When we immunoblotted
with an anti-FLAG antibody, we observed low levels of K1ΔNT. Thus, we re-probed this blot
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using an anti-K1 antibody, and saw expression of K1ΔNT but no K1ΔCT expression since the K1
antibody is directed towards an epitope on the K1 C-terminus (Fig 7C).
K1 facilitates AMPK activity in stressed cells
We found that K1 associates with AMPK and this association is important for the survival
advantage in stressed cells. We next wanted to determine the status of AMPK activity in
stressed EV and K1 expressing cells. We exposedHUVEC stably expressing empty vector (EV)
or FLAG-tagged K1 (K1) to media without serum and growth factors containing either com-
pound C or DMSO control for 24 hours. We then performed an AMPK-specific kinase activity
assay. We incubated lysate from EV or K1 expressing HUVECwith or without an AMPK sub-
strate, a synthetic peptide called SAMS peptide (HMRSAMSGLHLVKRR), AMP, and radiola-
beled γ-32P-ATP [53]. We next evaluated the incorporation of radiolabeled phosphate from γ-
32P-ATP into SAMS peptide. Compound C treatment resulted in an overall reduction in
AMPK activity in both EV and K1 expressing cells compared to untreated cells. However, in
the presence of compound C, we observed a higher degree of AMPK activity in K1 expressing
cells compared to EV expressing cells (Fig 8A). This data suggests that K1 expression promotes
Fig 7. K1 and AMPK association is important for cell survival following exposure to stress. (A) HEK-
293 cells stably expressing FLAG-tagged K1WT, K1ΔCT, K1ΔNT or empty vector (EV = pLenti CMV) were
treated with 10 or 7.5 μM compound C for 48 hours. The percent of metabolically active cells was determined
using the Promega MTS assay. The percent was derived by normalization to the DMSO (0.1%) control. Error
bars represent the standard deviation of biological triplicates. GraphPad Prism was used to determine one-
way ANOVA and Tukey’s post-test. **P<0.005 (B) Western blot showing expression of EV, K1WT, K1ΔCT,
and K1ΔNT using an anti-FLAG antibody. (C) Western blot from (Fig 7B) was stripped and probed for K1
using an anti-K1 antibody.
doi:10.1371/journal.ppat.1005985.g007
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AMPK activity in stressed cells.We also confirmed that K1 expression is not altered by nutrient
deprivation and compound C treatment by Western blot analysis (Fig 8B).
Discussion
Cell survival during KSHV infection is paramount to the establishment of life-long infection.
Upon infection, KSHV primarily enters a latent state. During latency, KSHV expresses a lim-
ited number of proteins and microRNAs that enable it to successfully persist in the cell by
avoiding the immune response and by promoting cell survival [54]. When KSHV reactivates
and enters the lytic stage, the cell must remain viable throughout viral replication and virion
assembly so that infectious virions are generated. Cell death prior to completion of the lytic
program would result in defective viral replication.
We observed that KSHV infected cells containing a WT K1 gene had a survival advantage
compared to cells infected with KSHV K1 mutants following exposure to stress. To explore the
underpinnings of this phenotype, we completed tandem affinity purification and mass spec-
trometry to identify K1-associating proteins. We identifiedAMPKγ1 as a K1-associating pro-
tein. We corroborated this finding independently and found that K1 co-immunoprecipitated
with AMPKγ1. By performing co-immunoprecipitations of AMPKγ1 and K1 domain mutants,
we found that the K1 N-terminus is important for K1 and AMPKγ1 association. The associa-
tion betweenK1 and AMPK is important for the survival advantage in stressed cells because
we observed reduced cell viability in cells expressing K1ΔNT compared to K1WT. Our studies
indicate that KSHV K1 promotes survival via its association with AMPK, and KSHV K1 facili-
tates AMPK activity in stressed cells.
To explore alternative possibilities for not observing the association betweenK1ΔNT and
AMPKγ1, we confirmed that K1ΔNT is not mislocalized in the cell and is expressed in the mem-
brane by performing a Western blot for K1ΔNT in the membrane fraction. Another explanation
Fig 8. K1-expression facilitates AMPK activity in stressed cells. (A) HUVEC stably expressing empty vector (EV)
or FLAG-K1 (K1) were deprived of serum and growth factors (starve) for 24 hours. At the time of starvation, 5 μM
compound C or DMSO (0.05%) was added. Each condition for EV and K1 was performed in triplicate. AMPK-specific
activity was determined by subtracting counts per minute (cpm) derived for each sample incubated without SAMS
peptide from cpm derived from each sample incubated with SAMS peptide. These values were then normalized to
total protein for each sample. The error bars represent the standard deviation of triplicates. *P<0.05 Student’s T test.
(B) Western blot of K1 and tubulin using lysate from the AMPK activity assay.
doi:10.1371/journal.ppat.1005985.g008
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for not observing association betweenAMPKγ1 and K1ΔNT may be that K1ΔNT may not fold
correctly due to the lack of the N-terminus.
Under normal culture conditions, our lab and others have shown that K1 activates the
PI3K/Akt/mTOR pathway [13, 18]. It has been reported that cells having overly active Akt and
consequently a high glycolytic rate are more sensitive to cell death following starvation com-
pared to control cells [55]. Moreover, when starved-cells are treated with an activator of
AMPK, cells with active Akt are protected from cell death [55]. KSHV-infected cells also have
an active PI3K/Akt/mTOR pathway and a high glycolytic rate [56–58]. Furthermore, simulta-
neous activation of AMPK, Akt and mTOR, has been observed in liver cancer cells following
nutrient starvation [59]. Thus, low levels of AMPK activation may promote metabolic adapta-
tion and consequently, increase KSHV-infected cell survival.We propose that K1 promotes
AMPK activity during metabolic stress and in this way enhances KSHV-infected cell survival.
We observed a modest reduction in the number of viable KSHV-K1WT cells following
knock down of the catalytic subunits, AMPKα1 and AMPKα2, compared to KSHV-K1WT cells
treated with non-specific siRNA (S2A Fig). This data suggests that in addition to promoting
cell survival via AMPK, K1 likely contributes to the survival advantage observed in
KSHV-K1WT cells by activating other pro-survival pathways such as the PI3K/Akt pathway as
has been previously described [18] [19, 20]. Thus, K1 promotes cell survival by multiple meth-
ods, including its association with AMPKγ1.
One of the K1-interacting proteins previously identified is Syk, a Src homology 2 (SH2)-
containing protein tyrosine kinase [13]. Activation of Syk in B cell lymphomas is associated
with cell survival since inhibition of Syk is clinically efficacious in treating lymphoma [60].
Moreover, Syk activity is critical for the normal functioning of endothelial cells and vascular
integrity in vivo. Syk deficient mice exhibit petechiae in utero, as well as, a reduced number of
endothelial cells that are morphologically defective, indicating that Syk activity is critical for
endothelial cell survival and function [61]. In vitro, Syk activity is important for HUVEC prolif-
eration and migration [62]. Huang et al. found that AMPK associates with Syk and induced its
activation [63]. Although the association of AMPK and Syk has not been evaluated in HUVEC,
we may speculate that the association of K1, AMPK, and Syk may facilitate downstream signal-
ing cascades that promote cell survival.
The role of AMPK during herpesvirus infection is complicated, and whether it promotes
viral replication or inhibits it may depend on a variety of factors. During human cytomegalovi-
rus (HCMV) infection, AMPK has been found to promote a metabolic environment that is
conducive to viral replication [64, 65]. HCMV infection augments glycolysis and AMPK inhi-
bition blocks increased glycolysis that is induced by HCMV infection and AMPK inhibition
also hinders viral DNA synthesis [65]. During human herpes simplex virus-1 (HSV-1) infec-
tion, AMPK activity facilitates neuron survival and reduces viral production [66]. Thus, AMPK
appears to impact viral production differently during HCMV and HSV-1 infection.
Recently, Cheng et al. observed that endogenous AMPKα1 inhibits KSHV replication fol-
lowing primary infection [67]. AMPK does not seem to affect KSHV infectivity nor trafficking
to the nucleus, but it does have an inhibitory effect on KSHV lytic gene expression since knock-
down of AMPK results in increased expression of some KSHV lytic genes and corresponding
proteins [67]. Thus, AMPK appeared to inhibit the KSHV lytic cycle but not the establishment
of latency.
Our studies examine the role of AMPK in a different context i.e. in latently infected cells
expressingWT or mutant K1 under conditions of metabolic stress. We report that AMPK
activity contributes to survival of latent KSHV-infected cells. BecauseAMPK can be activated
by a variety of cellular stresses and can impact multiple cell signaling pathways, it is highly
plausible that AMPK can differentially impact the infected-cell depending on the life-cycle of
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 14 / 23
the virus. There are also multiple isoforms of AMPK, and various combinations of these iso-
forms can form different heterotrimeric complexes. We do not yet understand how these dif-
ferent AMPK combinations modulate AMPK function, and this is an additional complexity
that we need to understand in the future in order to evaluate AMPK’s function during the
KSHV lifecycle.
Materials and Methods
Cell culture, transfections, and chemical compounds
HEK-293 (ATCC, CRL-1573) and iSLK cells [46] were maintained in Dulbecco’s Modified
EagleMedium (DMEM) and human telomerase-reverse transcriptase-immortalizedhuman
umbilical vein endothelial cells (hTERT-HUVEC) [17] were cultured in endothelial growth
basal medium (EBM-2) from Lonza and supplemented with an endothelial cell growth
medium (EGM-2) bullet kit without heparin and ascorbic acid supplements. All cell lines were
supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS), 1% penicillin-strepto-
mycin (PS), and 1% L-glutamine and maintained at 37°C and 5% CO2. Additionally, EV
(pcDNA3) or FLAG-K1 stably expressing HEK-293 cells were maintained in 1 mg/mLG418.
For transfection of HEK-293 cells, cells were transfected with 10 μg pcDNA3-V5-AMPKγ1 or
vector per 10 cm plate using XtremeGENE HP reagent according to the manufacturer’s
instructions. The AMPK inhibitor, compound C, was purchased from Calbiochem and sus-
pended in dimethyl sulfoxide (DMSO).
Constructs
HEK-293 cells stably expressing EV or FLAG-HA-K1 were made as previously described [50].
Briefly, FLAG-HA was cloned following the signal peptide sequence on the N-terminus of K1
(Accession# AAG01599.1). The FLAG-HA-K1 was then cloned into the pcDNA3 vector. A
V5-epitope tag was added to the N-terminus of PRKAG1 (NP_002724) by PCR and then
cloned into the pcDNA3 vector. The pcDNA3-K1WT that had previously beenmade [68] was
used as a template for preparing the K1 domain deletedmutants, which have been previously
described [50]. To construct pcDNA3-FLAG-K1ΔCT, pcDNA3-K1 WT (amino acids 1–303)
and the following primers, for-5’-CGCCCGAAGCTTATGGCCCTGCCCGTGACCGCCCTG-
3’ and rev-5’-CGCCACAAGGTTTCAGTACCAATCCACTGGTTG-3’ were combined for
amplification by PCR. The PCR product was then cut with HIND III and cloned into pcDNA3.
pcDNA3-FLAG-K1ΔCT lacks the amino acids 266–303. To construct pcDNA3-K1ΔNT-FLAG,
pcDNA3-K1WTwas combined with primers, for-5’-CATCTTGCATCCAGTATTTATGACA
C-3’ and rev-5’-CGCCGCTCTAGATTCCACTGGTTGCG-3’. The PCR product was then cut
with BamHI and XbaI, and cloned into pcDNA3. pcDNA3-K1ΔNT−FLAG lacks amino acids
1–241. The pcDNA3-K1WT construct was used as a template for making the lentiviral K1WT
and mutant constructs. pLenti-FLAG-K1 domain mutants were generated using Q5 Site-
DirectedMutagenesis kit (Q5) by New England Biolabs Inc and appropriate primer sets were
designed according to the Q5 kit specifications. FLAG-K1, FLAG-K1ΔCT, and FLAG-K1ΔNT
were cloned into the lentiviral vector, pLenti CMV Puro DEST. Empty vector is pLenti CMV
Puro. DEST.
Generation of stable cell lines
pcDNA3-FLAG-HA-K1 or pcDNA3 empty vector were transfected into HEK-293 cells and
selected in media containing 1 mg/mL G418. All lentiviruses were prepared using the Vira-
power lentiviral expression system as per the manufacturer’s instructions (Invitrogen).
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hTERT-HUVEC or HEK-293 cells were cultured to approximately 80% confluency in a 6-well
dish. At the time of lentiviral transduction, cells were rinsedwith PBS and 2 mLs of lentivirus
(unconcentrated) was added in the presence of 10 μg/mL polybrene. The cells were centrifuged
for 90 minutes at 3000 RCF at 30°C. The cells were then incubated overnight at 37°C and 5%
CO2. The media containing lentivirus was replaced with the appropriate fresh media the fol-
lowing day. Forty-eight hours following lentiviral transduction,HUVEC cells underwent selec-
tion with 0.5 μg/mL puromycin for 1 week. Transduced HEK-293 cells underwent selection
with 1 μg/mL puromycin for 1–2 weeks.
Tandem affinity purification
The FLAG HA Tandem Affinity PurificationKit by Sigma was used. FLAG-HA-K1 or EV
HEK-293 expressing cells were lysed and the lysates were incubated with anti-FLAGM2 affin-
ity gel, washed and eluted with 3X FLAG peptide. The eluates were subsequently incubated
with an anti-HA resin, washed with NP40 buffer and eluted. The eluates were resolved by sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie stained. Bands present in
the K1 sample but absent in the EV were submitted to the Harvard Mass Spectrometry core for
MALD/TOF/TOFmass spectroscopy analysis.
Trypan blue exclusion assay
EV or FLAG-HA-K1 stably expressing HEK-293 cells were plated at 650,000 cells/well in a
6-well dish or at 60,000/well in a 24-well dish. The next day, the media was removed and
replaced with complete media containing the relevant concentration of compound C. Six to
eight hours later the media from each well was collected; the cells were gently washed with PBS
and trypsinized.The cells were pelleted and resuspended in 0.6–1 mL complete media. An ali-
quot was removed for the trypan blue exclusion assay. The cells were then pelleted, the super-
natant was discarded and the pellets were immediately frozen and maintained at -80°C until
utilized for the caspase-3 assay. HUVEC infectedwith KSHV containingWTK1 or mutant K1
were plated at 20,000 cells per well of a 24-well plate in EBM-2 without serum and growth fac-
tors. Cells were not previously washed. iSLK cells containingWTK1 or mutant K1 were plated
in a similar manner, but in complete media. The next day, the iSLKmedia was replaced with
serum-freeDMEM. At the time of counting, cells were trypsinizedand cell suspension was
then combined with trypan blue (0.4% Sigma Aldrich) at a 1:1 dilution. Each sample was
counted in duplicate or triplicate using a hemacytometer.
Active caspase 3 assay
The previously frozen cell pellets were thawed on ice. The caspase-3 assay was then completed
based on the manufacturer’s instructions (ApoAlert Caspase-3 Fluorescent Assay by Clontech
Laboratories). Briefly, the pellets were lysed and maintained on ice followed by centrifugation.
The clarified supernatant was then assayed for active caspase-3 and fluorescencewas deter-
mined using the CLARIOstar plate reader (BMG Labtech). Active caspase-3 concentrations
were determined using a standard curve, and active caspase-3 values were then further normal-
ized to cell number.
MTS assay
Five thousand cells per 100 μL were counted and resuspended in EBM-2 containing 30 μg/mL
hygromycin but lacking all other supplements. Cells were plated in triplicate and incubated for
24, 48 and 72 hours. Cell proliferation was determined using the Cell Titer 96 Aqueous One
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Solution Cell Proliferation Assay (Promega) according to the manufacturer’s instructions.
Stored aliquots of previously frozenMTS were thawed in a water bath at 37°C. Twenty microli-
ters of MTS reagent was then dispensed into each well using a multichannel pipet. The plate
was then gently shaken for 30 seconds and placed in an incubator at 37°C for 2–3 hours. At the
end of incubation, the plate was gently tapped to mix the formazan product. The absorbance
was then immediately measured at 490 nm using a CLARIOstar plate reader (BMG Labtech).
Wells that contain only media were subtracted as background from all OD values. Elevated
absorbance values are indicative of metabolically active cells. For compound C treatments, we
normalized to vehicle treated cells. For the starvation of HUVEC, the same number of cells was
plated. In these experiments OD values are not normalized but show relative optical density
values.
Cell fractionation
HEK-293 stably expressing EV (pcDNA3) or FLAG-HA-K1 (pcDNA3) were washed, trypsi-
nized, centrifuged and counted. Five million cells were prepared using a cell fractionation kit
according to the manufacturer’s instructions (Cell Signaling Technology). Equal volumes of
each lysate from each fraction for EV and K1 were loaded and resolved by sodiumdodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a nitrocellulose
membrane.
Immunoblots
Cells were harvested, washed twice with PBS, and then lysed in buffer containing 0.5% NP40,
150 mMNaCl, 50 mM Tris-HCL pH 8.0, and a cocktail of proteinase (Roche) and phosphatase
(Roche) inhibitors. The lysates used to evaluate K1 protein expression were frozen and thawed
two times. Protein concentrations were determined by Bradford assay. Equal amounts of pro-
tein (15–25 μg) were loaded per lane and resolved by SDS-PAGE and then transferred to a
nitrocellulosemembrane. The following antibodies from Cell Signaling Technology were used:
AMPKα #2603, AMPKα1 #2795, AMPKα2 #2757, AMPKβ1 #12063, AMPKβ1/2 #4150,
AMPKγ1#4187, HRP-linked anti-rabbit IgG #7074 and HRP-linked anti-mouse IgG #7076. In
some experiments K1 expression was confirmed by immunoblotting with an HRP-conjugated
mouse monoclonal anti-FLAGM2 antibody from Sigma #F1804. The K1 monoclonal antibody
was made by immunization with the peptide, KQRDSNKTVP, protein ID#AAB71616 (gene
accession #U86667).
Co-immunoprecipitations
Lysates containing equal amounts of protein as determined by the Bradford assay or bicincho-
ninic acid assay (BCA assay) were combined with EZview Red anti-FLAGM2 affinity gel
(Sigma, F2426) as per the manufacturer’s instructions. For V5-AMPKγ1 immunoprecipitation,
protein A/G agarose (Santa Cruz, sc-2003) was combined with monoclonal anti-V5 antibody
(Sigma, V8012), which was used at 1ug of antibody/1mg of protein, and rotated overnight at
4°C. The supernatant was removed and the affinity gel or agarose pellets were washed by add-
ing 1mL of 0.1% NP40 lysis buffer followed by 5 minutes rotation at 4°C for a total of 4 times.
For immunoprecipitation using the membrane fraction, affinity gel pellets were washed with
1mL of 0.1% NP40 lysis buffer, followed by 5 minutes rotation at 4°C for 3 times and with 1mL
0.5% NP40 lysis buffer followed by 5 minutes rotation at 4°C for one time. Detergent was then
removed from the membrane fraction using Pierce Detergent spin columns. FLAG-K1 and/or
FLAG-K1 domain deletedmutants were eluted using 3X FLAG peptide (Sigma, F4799) as per
the manufacturer’s instructions. Laemmli buffer (2X) was added to the FLAG-K1eluate or
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directly to the V5-AMPKγ1/agarose samples (1:1) and all samples were heated at 100°C for 6
minutes. Proteins were resolved by SDS-PAGE followed by Western blot.
AMPK activity assay
HUVEC stably expressing EV or FLAG-K1 were incubated in EBM-2 without serum and
growth factors for 24 hours. Either 5 uM compound C or DMSO (0.05%) control was added at
the start of starvation. Cells were washed with cold PBS and then lysed with a buffer containing
50mM Tris-HCL pH 7.4, 1 mM EDTA, 1 mM EGTA, 250 mMmannitol, 1% Triton X-100 and
proteinase (Roche) and phosphatase inhibitors (Roche). Lysates were then clarified by centrifu-
gation. For the AMPK activity assay, reagents were purchased from SignalChemand the manu-
facturer’s protocol followed. Briefly, 10 μLs of cell lysate was incubated with 5 μL of 1 mg/mL
SAMS or peptide substrate solution, 5 μLs 0.5 mMAMP solution and 5 μLs γ-32P-ATP assay
cocktail. Gamma-32P-ATP was purchased from Perkin Elmer. The mixture was incubated at
room temperature for 30 minutes and then 20 μLs was added to phosphocellulose paper and
washed 2 times in 1% phosphoric acid solution. Counts per minute (cpm) were acquired using
a PerkinElmer liquid scintillation analyzer.
Immunofluorescence and confocal microscopy
Approximately 120,000 HUVEC cells stably expressing EV or FLAG-K1 were plated inMatTek
35 mm glass-bottom dishes. Cells were washed with PBS and fixed by 15-minute incubation in
3.7% formaldehyde at room temperature. Cells were washed 3X with PBS and then permeabi-
lized by 15-minute incubation at room temperature in 0.2% Triton-X 100/PBS. Cells were then
washed again 3X with PBS and then blocked in 10% bovine serum albumin (BSA) PBS for 30
minutes. Cells were stained 1:200 with a directly conjugated FITC-ECS (DDDDK) polyclonal
antibody (Bethyl laboratories) and anti-AMPKβ1/2 (1:50, Cell Signaling) in 10% BSA for 1
hour at room temperature. Cells were washed 2X quick followed by 3X 5-minute washes. Sam-
ples were then incubated with anti-rabbit Alexa Fluor 647 (1:600) secondary antibody in 10%
BSA at room temperature for 1 hour. All samples were then stained with DAPI for 1 minute
and washed. Fluorescent images were acquired by taking z-stacks using a 63X oil objective on a
Zeiss 700 confocal microscope. The overlap coefficient according to Manders (R) was deter-
mined using Image J. Confocal images from 5 cells in their entirety were evaluated for co-local-
ization by calculating the overlap coefficient.
Generation of WT or mutant K1 recombinant viruses
The construction of the KSHVWT and mutant recombinant viruses has previously been
described in detail [46]. Briefly, the BAC 16 was kindly provided by Dr. Jae U. Jung. pcDNA3
WT and mutant K1 constructs were used as templates for construction of recombinant viruses.
pcDNA3 WT K1FLAG, which has a FLAG tag at the N-terminus, was constructed as previously
described [68]. The pcDNA3-K15XSTOP construct has 3 stop codons following the start codon
of WT K1 FLAG and two TGA stop codons replacing ATG start codons at positions 481 and
763. K15XSTOP was inserted into BamHI and EcoRI sites of pcDNA3 WTK1FLAG. The original
K1 gene is located within the BAC16 genome at position 105 to 959. KSHV-K1REV was made
by replacing the mutant K1 gene from KSHV-K15XSTOP with a RpsL-Neo cassette and then
replaced the RpsL-Neo cassette withWT K1FLAG. The recombinant viruses containing
KSHV-K1WT, KSHV-K15XSTOP, KSHVΔK1 and KSHV-K1REV were made utilizing the Red/ET
recombination system (Gene Bridges Inc) as per the manufacturer’s instructions. KSHVΔK1
was constructed by replacing the K1 gene with the linear RpsL-neo cassette that is flanked by
homologous arms [46].
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Establishment of cells stably infected with WT or mutant K1 recombinant
viruses
Five × 105 cells of WT or recombinant virus infected iSLK cells were plated in one well of a 6-
well plate overnight after which cells were reactivated with 3 μg/ml doxycycline and 1 mM
sodium butyrate for 3 days. Supernatant was collected and cleared by centrifugation at 950g for
10 min and filtered through a 0.45 μm filter. iSLK cells were infected as previously described
[46] and maintained in the presence of 1 μg/ml puromycin, 250 μg/mLG418, and 1.2 mg/mL
hygromycin [46]. In order to infect HUVEC, the filtered viral supernatants from reactivated
iSLK cells were incubated with the immortalizedHUVEC cells in the presence of 8 μg/ml of
polybrene and centrifuged for 2 hours at 3000 RCF at 30°C. The cells were then placed in an
incubator with 5% CO2 at 37°C. At 48 hours post-infection, 30 μg/ml hygromycin was added
to the media to select for HUVEC stably infected with KSHV-K1WT, KSHV-K15XSTOP,
KSHVΔK1 or KSHV-K1REV (revertant) recombinant viruses. The infectedHUVEC cells were
also maintained in the presence of 30 μg/ml hygromycin.
Supporting Information
S1 Fig. Cell viability following starvation and then nutrient replenishment. (A) Cell viability
was determined by trypan blue exclusion assay in HUVEC infectedwith KSHV-K1WT, KSHV-
K15XSTOP, KSHVΔK1, and KSHV-K1REV following serum and growth factor starvation for 72
hours. (B) HUVEC infected with KSHV-K1WT, KSHV-K15XSTOP, KSHVΔK1, and KSHV-
K1REV were deprived of serum and growth factors for 72 hours. At 72 hours nutrients were
replenished. Cell viability was determined by trypan blue exclusion assay after 72 hours post
nutrient replenishment.
(TIF)
S2 Fig. Reduced cell viability in HUVEC stably infectedwith KSHV-K1WT following treat-
ment with AMPKα1/AMPKα2 siRNA compared to KSHV-K1WT treated with non-specific
siRNA (NS).HUVEC cells were transiently transfected with AMPKα1 and AMPKα2 siRNA
or non-specific (NS) siRNA. (A) Cell viability was evaluated by determiningATP levels using
an ATP luminescence assay (Promega) at 48 and 72 hours post transfection. (B) AMPKα1 and
AMPKα2 expression in the lysates from (A) at 72 hours post transfection was determined by
SDS-PAGE andWestern blot. Student’s t test, P<0.05.
(TIF)
S3 Fig. Mass Spectrometryof K1 interacting proteins. A) Stable cell lines expressing a FLAG
and HA double epitope-tagged version of K1 and EV HEK-293 cells were subjected to tandem
affinity purification. FLAG-HA-K1 or EV HEK-293 expressing cells were lysed and the lysates
were incubated with anti-FLAGM2 affinity gel, washed and eluted with 3X FLAG peptide. The
eluates were subsequently incubated with an anti-HA resin, washed with NP40 buffer and
eluted. The eluates were resolved by sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and Coomassie stained. B) The eluates from (A) were also subjected to SDS-PAGE andWest-
ern blot analysis with an anti-FLAG antibody to detect the presence of the monomer and oligo-
meric forms of K1.
(TIF)
Acknowledgments
We would like to thank Dr. Jae Jung for the original KSHV BAC16 construct.We thank the
UNCMicroscopy ServiceLaboratorymembers, particularly Dr. Robert Bagnell, for their
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 19 / 23
assistance. We also thank Damania lab members for helpful advice. BD is a Leukemia and
Lymphoma Society Scholar, and a BurroughsWellcome Fund Investigator in Infectious
Disease.
Author Contributions
Conceived and designed the experiments:PMA PMB BD.
Performed the experiments:PMA ZZ PMB.
Analyzed the data: PMA ZZ PMB BD.
Contributed reagents/materials/analysis tools: PMA ZZ PMB BD LG.
Wrote the paper:PMA BD.
References
1. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi’s sarcoma-
associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995; 86
(4):1276–80. PMID: 7632932
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvi-
rus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994; 266(5192):1865–9.
PMID: 7997879
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-
like DNA sequences in AIDS-related body-cavity-based lymphomas. The New England journal of med-
icine. 1995; 332(18):1186–91. doi: 10.1056/NEJM199505043321802 PMID: 7700311
4. Oh JK, Weiderpass E. Infection and Cancer: Global Distribution and Burden of Diseases. Annals of
global health. 2014; 80(5):384–92. doi: 10.1016/j.aogh.2014.09.013 PMID: 25512154
5. Parkin DM. The global health burden of infection-associated cancers in the year 2002. International
journal of cancer Journal international du cancer. 2006; 118(12):3030–44. doi: 10.1002/ijc.21731
PMID: 16404738
6. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, et al. Nucleotide sequence of the
Kaposi sarcoma-associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences of
the United States of America. 1996; 93(25):14862–7. PMID: 8962146
7. Fields virology [electronic resource]. Fields BN, Howley PM, Knipe DM, editors. Philadelphia: Wolters
Kluwer Health/Lippincott Williams & Wilkins; 2013.
8. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. Toll-like receptor signaling con-
trols reactivation of KSHV from latency. Proceedings of the National Academy of Sciences of the
United States of America. 2009; 106(28):11725–30. doi: 10.1073/pnas.0905316106 PMID: 19564611
9. Bowser BS, DeWire SM, Damania B. Transcriptional regulation of the K1 gene product of Kaposi’s sar-
coma-associated herpesvirus. Journal of virology. 2002; 76(24):12574–83. doi: 10.1128/JVI.76.24.
12574-12583.2002 PMID: 12438583
10. Chandriani S, Ganem D. Array-based transcript profiling and limiting-dilution reverse transcription-
PCR analysis identify additional latent genes in Kaposi’s sarcoma-associated herpesvirus. Journal of
virology. 2010; 84(11):5565–73. doi: 10.1128/JVI.02723-09 PMID: 20219929
11. Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, et al. KSHV 2.0: a compre-
hensive annotation of the Kaposi’s sarcoma-associated herpesvirus genome using next-generation
sequencing reveals novel genomic and functional features. PLoS pathogens. 2014; 10(1):e1003847.
doi: 10.1371/journal.ppat.1003847 PMID: 24453964
12. Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M, et al. Identification of an immunoreceptor
tyrosine-based activation motif of K1 transforming protein of Kaposi’s sarcoma-associated herpesvi-
rus. Molecular and cellular biology. 1998; 18(9):5219–28. PMID: 9710606
13. Lee BS, Lee SH, Feng P, Chang H, Cho NH, Jung JU. Characterization of the Kaposi’s sarcoma-asso-
ciated herpesvirus K1 signalosome. Journal of virology. 2005; 79(19):12173–84. doi: 10.1128/JVI.79.
19.12173-12184.2005 PMID: 16160144
14. Lagunoff M, Majeti R, Weiss A, Ganem D. Deregulated signal transduction by the K1 gene product of
Kaposi’s sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences of the
United States of America. 1999; 96(10):5704–9. PMID: 10318948
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 20 / 23
15. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, et al. Deregulation of cell growth by the K1 gene of
Kaposi’s sarcoma-associated herpesvirus. Nature medicine. 1998; 4(4):435–40. PMID: 9546789
16. Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G, et al. Tumorigenesis and aberrant signaling in
transgenic mice expressing the human herpesvirus-8 K1 gene. Journal of the National Cancer Insti-
tute. 2002; 94(12):926–35. PMID: 12072546
17. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B. Immortalization of primary endothelial
cells by the K1 protein of Kaposi’s sarcoma-associated herpesvirus. Cancer research. 2006; 66
(7):3658–66. doi: 10.1158/0008-5472.CAN-05-3680 PMID: 16585191
18. Tomlinson CC, Damania B. The K1 protein of Kaposi’s sarcoma-associated herpesvirus activates the
Akt signaling pathway. Journal of virology. 2004; 78(4):1918–27. doi: 10.1128/JVI.78.4.1918-1927.
2004 PMID: 14747556
19. Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, et al. K1 protein of human herpesvirus
8 suppresses lymphoma cell Fas-mediated apoptosis. Blood. 2007; 109(5):2174–82. doi: 10.1182/
blood-2006-02-003178 PMID: 17090655
20. Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F. Mechanism of Fas signaling regulation by
human herpesvirus 8 K1 oncoprotein. Journal of the National Cancer Institute. 2009; 101(6):399–411.
doi: 10.1093/jnci/djn516 PMID: 19276446
21. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev
Mol Cell Biol. 2007; 8(10):774–85. doi: 10.1038/nrm2249 PMID: 17712357
22. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated pro-
tein kinase subfamily. The Journal of biological chemistry. 1996; 271(2):611–4. PMID: 8557660
23. Gao G, Fernandez CS, Stapleton D, Auster AS, Widmer J, Dyck JR, et al. Non-catalytic beta- and
gamma-subunit isoforms of the 5’-AMP-activated protein kinase. The Journal of biological chemistry.
1996; 271(15):8675–81. PMID: 8621499
24. Thornton C, Snowden MA, Carling D. Identification of a novel AMP-activated protein kinase beta sub-
unit isoform that is highly expressed in skeletal muscle. The Journal of biological chemistry. 1998; 273
(20):12443–50. PMID: 9575201
25. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein
kinase gamma-subunit isoforms and their role in AMP binding. The Biochemical journal. 2000; 346 Pt
3:659–69. PMID: 10698692
26. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, et al. AMP-activated protein kinase:
greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2
isoform. The Biochemical journal. 1998; 334 (Pt 1):177–87. PMID: 9693118
27. Warden SM, Richardson C, O’Donnell J Jr., Stapleton D, Kemp BE, Witters LA. Post-translational
modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular
localization. The Biochemical journal. 2001; 354(Pt 2):275–83. PMID: 11171104
28. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and devel-
opmental expression of AMP-activated protein kinase isoforms in mouse central nervous system.
Journal of neurochemistry. 1999; 72(4):1707–16. PMID: 10098881
29. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. Functional domains of the alpha1 catalytic sub-
unit of the AMP-activated protein kinase. The Journal of biological chemistry. 1998; 273(52):35347–
54. PMID: 9857077
30. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeo-
stasis. Nat Rev Mol Cell Biol. 2012; 13(4):251–62. doi: 10.1038/nrm3311 PMID: 22436748
31. Gowans GJ, Hardie DG. AMPK: a cellular energy sensor primarily regulated by AMP. Biochemical
Society transactions. 2014; 42(1):71–5. doi: 10.1042/BST20130244 PMID: 24450630
32. Hong SP, Leiper FC, Woods A, Carling D, Carlson M. Activation of yeast Snf1 and mammalian AMP-
activated protein kinase by upstream kinases. Proceedings of the National Academy of Sciences of
the United States of America. 2003; 100(15):8839–43. doi: 10.1073/pnas.1533136100 PMID:
12847291
33. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al. LKB1 is the upstream
kinase in the AMP-activated protein kinase cascade. Current biology: CB. 2003; 13(22):2004–8.
PMID: 14614828
34. Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, et al. Adenosine monophosphate-
activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ische-
mia-reperfusion injury in the rat. Hepatology. 2001; 34(6):1164–73. doi: 10.1053/jhep.2001.29197
PMID: 11732006
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 21 / 23
35. Marsin AS, Bouzin C, Bertrand L, Hue L. The stimulation of glycolysis by hypoxia in activated mono-
cytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. The Jour-
nal of biological chemistry. 2002; 277(34):30778–83. doi: 10.1074/jbc.M205213200 PMID: 12065600
36. Lee M, Hwang JT, Lee HJ, Jung SN, Kang I, Chi SG, et al. AMP-activated protein kinase activity is criti-
cal for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic
conditions in DU145 cells. The Journal of biological chemistry. 2003; 278(41):39653–61. doi: 10.1074/
jbc.M306104200 PMID: 12900407
37. Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, et al. 5’-AMP-activated protein
kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor
microenvironments. Molecular and cellular biology. 2006; 26(14):5336–47. doi: 10.1128/MCB.00166-
06 PMID: 16809770
38. Jeon SM, Hay N. The double-edged sword of AMPK signaling in cancer and its therapeutic implica-
tions. Arch Pharm Res. 2015; 38(3):346–57. doi: 10.1007/s12272-015-0549-z PMID: 25575627
39. Jeon SM, Hay N. The dark face of AMPK as an essential tumor promoter. Cell Logist. 2012; 2(4):197–
202. doi: 10.4161/cl.22651 PMID: 23676995
40. Chhipa RR, Wu Y, Mohler JL, Ip C. Survival advantage of AMPK activation to androgen-independent
prostate cancer cells during energy stress. Cellular signalling. 2010; 22(10):1554–61. doi: 10.1016/j.
cellsig.2010.05.024 PMID: 20570728
41. Park HU, Suy S, Danner M, Dailey V, Zhang Y, Li H, et al. AMP-activated protein kinase promotes
human prostate cancer cell growth and survival. Molecular cancer therapeutics. 2009; 8(4):733–41.
doi: 10.1158/1535-7163.MCT-08-0631 PMID: 19372545
42. Vucicevic L, Misirkic M, Janjetovic K, Harhaji-Trajkovic L, Prica M, Stevanovic D, et al. AMP-activated
protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of com-
pound C. Biochemical pharmacology. 2009; 77(11):1684–93. doi: 10.1016/j.bcp.2009.03.005 PMID:
19428322
43. Baumann P, Mandl-Weber S, Emmerich B, Straka C, Schmidmaier R. Inhibition of adenosine mono-
phosphate-activated protein kinase induces apoptosis in multiple myeloma cells. Anticancer Drugs.
2007; 18(4):405–10. doi: 10.1097/CAD.0b013e32801416b6 PMID: 17351392
44. Yang WL, Perillo W, Liou D, Marambaud P, Wang P. AMPK inhibitor compound C suppresses cell pro-
liferation by induction of apoptosis and autophagy in human colorectal cancer cells. J Surg Oncol.
2012; 106(6):680–8. doi: 10.1002/jso.23184 PMID: 22674626
45. Jang T, Calaoagan JM, Kwon E, Samuelsson S, Recht L, Laderoute KR. 5’-AMP-activated protein
kinase activity is elevated early during primary brain tumor development in the rat. International journal
of cancer Journal international du cancer. 2011; 128(9):2230–9. doi: 10.1002/ijc.25558 PMID:
20635388
46. Zhang Z, Chen W, Sanders MK, Brulois KF, Dittmer DP, Damania B. The K1 Protein of Kaposi’s Sar-
coma-Associated Herpesvirus Augments Viral Lytic Replication. Journal of virology. 2016; 90
(17):7657–66. doi: 10.1128/JVI.03102-15 PMID: 27307571
47. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.
Genes & development. 2011; 25(18):1895–908.
48. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase
in mechanism of metformin action. The Journal of clinical investigation. 2001; 108(8):1167–74. doi: 10.
1172/JCI13505 PMID: 11602624
49. Accordi B, Galla L, Milani G, Curtarello M, Serafin V, Lissandron V, et al. AMPK inhibition enhances
apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells. Leukemia. 2013; 27
(5):1019–27. doi: 10.1038/leu.2012.338 PMID: 23228943
50. Wen KW, Damania B. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic func-
tion of KSHV K1. Oncogene. 2010; 29(24):3532–44. doi: 10.1038/onc.2010.124 PMID: 20418907
51. Lee BS, Alvarez X, Ishido S, Lackner AA, Jung JU. Inhibition of intracellular transport of B cell antigen
receptor complexes by Kaposi’s sarcoma-associated herpesvirus K1. The Journal of experimental
medicine. 2000; 192(1):11–21. PMID: 10880522
52. Tomlinson CC, Damania B. Critical role for endocytosis in the regulation of signaling by the Kaposi’s
sarcoma-associated herpesvirus K1 protein. Journal of virology. 2008; 82(13):6514–23. doi: 10.1128/
JVI.02637-07 PMID: 18434405
53. Davies SP, Carling D, Hardie DG. Tissue distribution of the AMP-activated protein kinase, and lack of
activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide
assay. Eur J Biochem. 1989; 186(1–2):123–8. PMID: 2574667
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 22 / 23
54. Giffin L, Anders P, Damania B. Kaposi’s Sarcoma-Associated Herpesvirus: Pathogenesis and Host
Immune Response. In: Hudnall SD, editor. Viruses and Human Cancer. New York: Springer Science;
2014. p. 289–322.
55. Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, et al. The glucose
dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-
oxidation. Oncogene. 2005; 24(26):4165–73. doi: 10.1038/sj.onc.1208622 PMID: 15806154
56. Bhatt AP, Jacobs SR, Freemerman AJ, Makowski L, Rathmell JC, Dittmer DP, et al. Dysregulation of
fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proceedings of the National Academy of
Sciences of the United States of America. 2012; 109(29):11818–23. doi: 10.1073/pnas.1205995109
PMID: 22752304
57. Delgado T, Carroll PA, Punjabi AS, Margineantu D, Hockenbery DM, Lagunoff M. Induction of the War-
burg effect by Kaposi’s sarcoma herpesvirus is required for the maintenance of latently infected endo-
thelial cells. Proceedings of the National Academy of Sciences of the United States of America. 2010;
107(23):10696–701. doi: 10.1073/pnas.1004882107 PMID: 20498071
58. Bhatt AP, Bhende PM, Sin SH, Roy D, Dittmer DP, Damania B. Dual inhibition of PI3K and mTOR
inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood.
2010; 115(22):4455–63. doi: 10.1182/blood-2009-10-251082 PMID: 20299510
59. Murata Y, Uehara Y, Hosoi Y. Activation of mTORC1 under nutrient starvation conditions increases
cellular radiosensitivity in human liver cancer cell lines, HepG2 and HuH6. Biochemical and biophysical
research communications. 2015; 468(4):684–90. doi: 10.1016/j.bbrc.2015.11.016 PMID: 26585486
60. Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, et al. Inhibition of Syk
with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lym-
phocytic leukemia. Blood. 2010; 115(13):2578–85. doi: 10.1182/blood-2009-08-236471 PMID:
19965662
61. Yanagi S, Inatome R, Ding J, Kitaguchi H, Tybulewicz VL, Yamamura H. Syk expression in endothelial
cells and their morphologic defects in embryonic Syk-deficient mice. Blood. 2001; 98(9):2869–71.
PMID: 11675365
62. Inatome R, Yanagi S, Takano T, Yamamura H. A critical role for Syk in endothelial cell proliferation and
migration. Biochemical and biophysical research communications. 2001; 286(1):195–9. doi: 10.1006/
bbrc.2001.5355 PMID: 11485328
63. Chang MY, Huang DY, Ho FM, Huang KC, Lin WW. PKC-dependent human monocyte adhesion
requires AMPK and Syk activation. PloS one. 2012; 7(7):e40999. doi: 10.1371/journal.pone.0040999
PMID: 22848421
64. Terry LJ, Vastag L, Rabinowitz JD, Shenk T. Human kinome profiling identifies a requirement for AMP-
activated protein kinase during human cytomegalovirus infection. Proceedings of the National Acad-
emy of Sciences of the United States of America. 2012; 109(8):3071–6. doi: 10.1073/pnas.
1200494109 PMID: 22315427
65. McArdle J, Moorman NJ, Munger J. HCMV targets the metabolic stress response through activation of
AMPK whose activity is important for viral replication. PLoS pathogens. 2012; 8(1):e1002502. doi: 10.
1371/journal.ppat.1002502 PMID: 22291597
66. Leyton L, Hott M, Acuna F, Caroca J, Nunez M, Martin C, et al. Nutraceutical activators of AMPK/Sirt1
axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-
1 infection. Virus research. 2015; 205:63–72. doi: 10.1016/j.virusres.2015.05.015 PMID: 26031763
67. Cheng F, He M, Jung JU, Lu C, Gao SJ. Suppression of Kaposi’s sarcoma-associated herpesvirus
infection and replication by 5’ AMP-activated protein kinase. Journal of virology. 2016.
68. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS, et al. The Kaposi’s sarcoma-
associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion fac-
tors. Cancer research. 2004; 64(8):2774–81. PMID: 15087393
KSHV K1 Modulates AMPK Function
PLOS Pathogens | DOI:10.1371/journal.ppat.1005985 November 9, 2016 23 / 23
